Cargando…

A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case–control study

BACKGROUND: As the management of patients treated with anticoagulants and antiplatelet drugs entails balancing coagulation levels, we evaluated the net clinical benefit of warfarin and aspirin on stroke in a large cohort of patients with atrial fibrillation (AF). METHODS: A population-based cohort s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azoulay, Laurent, Dell’Aniello, Sophie, Simon, Teresa A, Langleben, David, Renoux, Christel, Suissa, Samy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3444325/ https://www.ncbi.nlm.nih.gov/pubmed/22734842 http://dx.doi.org/10.1186/1471-2261-12-49

Ejemplares similares

Cardiac glycosides use and the risk of lung cancer: a nested case–control study
por: Couraud, Sébastien, et al.
Publicado: (2014)

Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
por: Loo, Simone Y, et al.
Publicado: (2018)

Pramipexole use and the risk of pneumonia
por: Ernst, Pierre, et al.
Publicado: (2012)

Incidence, Mortality, and Sex Differences of Non‐Valvular Atrial Fibrillation: A Population‐Based Study
por: Renoux, Christel, et al.
Publicado: (2014)

Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study
por: Martinez, Carlos, et al.
Publicado: (2010)

Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study
por: Renoux, Christel, et al.
Publicado: (2016)

Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality
por: Suissa, Samy, et al.
Publicado: (2012)

Single-Inhaler Triple versus Dual Bronchodilator Therapy in COPD: Real-World Comparative Effectiveness and Safety
por: Suissa, Samy, et al.
Publicado: (2022)

Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study
por: Douros, Antonios, et al.
Publicado: (2018)

Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study
por: Ernst, Pierre, et al.
Publicado: (2011)

Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer
por: Huiart, L, et al.
Publicado: (2011)

Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study
por: Renoux, Christel, et al.
Publicado: (2015)

Trends in initiation of direct oral anticoagulant therapies for atrial fibrillation in a national population-based cross-sectional study in the French health insurance databases
por: Huiart, Laetitia, et al.
Publicado: (2018)

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation
por: Simon, Teresa A., et al.
Publicado: (2016)

Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
por: Allan, Victoria, et al.
Publicado: (2017)

Warfarin therapy in atrial fibrillation: assessment of patient knowledge of risks and benefits
por: Fitzgerald, P., et al.
Publicado: (2020)

Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban
por: Winkle, Roger A., et al.
Publicado: (2014)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
por: Molteni, Mauro, et al.
Publicado: (2014)

Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study
por: Lapi, Francesco, et al.
Publicado: (2013)

Effect of warfarin versus aspirin on blood viscosity in cardioembolic stroke with atrial fibrillation: a prospective clinical trial
por: Lee, Chan-Hyuk, et al.
Publicado: (2019)

The use of warfarin in veterans with atrial fibrillation
por: Bravata, Dawn M, et al.
Publicado: (2004)

Metformin and the Risk of Cancer: Time-related biases in observational studies
por: Suissa, Samy, et al.
Publicado: (2012)

Response to Comment on: Smiechowski et al. The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes. Diabetes Care 2013;36:124–129
por: Suissa, Samy, et al.
Publicado: (2013)

Response to Bodmer et al. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Suissa, Samy, et al.
Publicado: (2013)

Response to Yang and Chan. Metformin and the Risk of Cancer: Time-Related Biases in Observational Studies. Diabetes Care 2012;35:2665–2673
por: Suissa, Samy, et al.
Publicado: (2013)

Net Clinical Benefit of Left Atrial Appendage Closure Versus Warfarin in Patients With Atrial Fibrillation: A Pooled Analysis of the Randomized PROTECT‐AF and PREVAIL Studies
por: Brouwer, Tom F., et al.
Publicado: (2019)

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study
por: Azoulay, Laurent, et al.
Publicado: (2012)

Point of care testing for improving risk- benefit ratio of aspirin and warfarin
por: Sheth, Harsh, et al.
Publicado: (2014)

Inappropriate combination of warfarin and aspirin
por: Turan, Burak, et al.
Publicado: (2016)

Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease
por: Renoux, Christel, et al.
Publicado: (2016)

Benefit, risk and cost of new oral anticoagulants and warfarin in atrial fibrillation; A multicriteria decision analysis
por: Mendoza-Sanchez, Jose, et al.
Publicado: (2018)

Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol
por: Li, Guowei, et al.
Publicado: (2015)

Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?
por: Lin, Dong, et al.
Publicado: (2021)

Associations of anaemia with bleeding and thrombotic complications in patients with atrial fibrillation treated with warfarin: a registry-based nested case–control study
por: Helin, Tuukka Antero, et al.
Publicado: (2023)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
por: Hansen, Carolina Malta, et al.
Publicado: (2012)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
por: Touchette, Daniel R., et al.
Publicado: (2008)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
por: Benamer, Sufyan, et al.
Publicado: (2016)

Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation
por: Christersson, Christina, et al.
Publicado: (2019)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Rashid, Sana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e1tdskvdgi1p768s96l2qrq54c